(en) Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Chinnaiyan AM et al., « Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression », Nature, vol. 457, no 7231, , p. 910-4. (PMID19212411, PMCIDPMC2724746, DOI10.1038/nature07762, lire en ligne [html])
(en) Lane H, Huang C, Wu P, Liu Y, Chang Y, Lin P, Chen P, Tsai G, « Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia », Biol Psychiatry, vol. 60, no 6, , p. 645-9. (PMID16780811)
(en) Tsai G, Lane H, Yang P, Chong M, Lange N, « Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia », Biol Psychiatry, vol. 55, no 5, , p. 452-6. (PMID15023571)
(en) Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Chinnaiyan AM et al., « Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression », Nature, vol. 457, no 7231, , p. 910-4. (PMID19212411, PMCIDPMC2724746, DOI10.1038/nature07762, lire en ligne [html])
(en) Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Chinnaiyan AM et al., « Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression », Nature, vol. 457, no 7231, , p. 910-4. (PMID19212411, PMCIDPMC2724746, DOI10.1038/nature07762, lire en ligne [html])